RxDoctor Payments Data

Catherine Rezendes, DPM

Podiatrist · Live Oak, TXNPI 1720002579

Payments from drug & device makers

What this record shows

This record is dominated by other: $25,200 of the $33,121 with a category attached, or 76.1%. Convatec Inc. accounts for 86.2% of it on its own, with 21 other manufacturers making up the rest. 2025 is the largest year on record at $26,247, more than ten times the $125 reported in 2019. Among podiatrist clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$33,121in general payments, 2019–2025

Across 169 payments — averaging $195.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$29K
  • Triad Life Sciences Inc.$2K
  • Paratek Pharmaceuticals, Inc.$899
  • Kerecis Limited$623
  • Organogenesis Inc.$419
  • Nevro Corp.$175
  • plus $825 from 16 others

What the payments were for

  • Travel & lodging$2,8078%
  • Food & beverage$5,11515%
  • Other$25,20076%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,121 in reported general payments places this provider in the 90th percentile of 470 podiatrist providers in Texas.

See all podiatrist providers in Texas

Medicare billing

Part B allowed, 2024
$35,239
Medicare patients
272
Services billed
523

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium17$1,524
Ketoconazole40$1,241
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort21$778
Clotrimazole18$465
Mupirocin44$418
Pregabalin12$388
Gabapentin14$204
Duloxetine Hcl13$203
Terbinafine Hcl14$198
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$122
Methylprednisolone12$105
Meloxicam50$82
Cephalexin11$76

Paid to pharmacies, not to this prescriber.

Other podiatrist in Live Oak

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →